Exenatide vs Ipilimumab

## Exenatide vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Exenatide** and **Ipilimumab**.

## Mechanism of Action

**Exenatide**: Synthetic exendin-4 GLP-1 receptor agonist enhancing glucose-dependent insulin secretion.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Exenatide — 2.4 hours; Ipilimumab — 14.7 days.

## Chemical Properties

**Type**: Exenatide — Protein; Ipilimumab — Antibody.